Literature DB >> 8614748

Estimation of expected quality adjusted survival by cross-sectional survey.

J S Hwang1, J Y Tsauo, J D Wang.   

Abstract

To compare both mortality and quality of life (QOL) across different illnesses, we propose an estimator to calculate the expected quality adjusted survival (QAS) by multiplying the QOL into the survival function. While the survival function can be determined by the usual life table method, the QOL data can be collected by a cross-sectional survey among patients who are currently surviving. The area under the QAS curve is thus the expected utility of health of the specific illness, which may take a common unit of quality adjusted life year ready for outcome evaluation and policy decision. A simulation is performed to demonstrate that the proposed estimator and its standard error are relatively accurate. The limitations and guidelines for using this estimator are also discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8614748     DOI: 10.1002/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Expressing estimators of expected quality adjusted survival as functions of Nelson-Aalen estimators.

Authors:  Y Huang; T A Louis
Journal:  Lifetime Data Anal       Date:  1999-09       Impact factor: 1.588

2.  Integrating health profile with survival for quality of life assessment.

Authors:  Jing-Shiang Hwang; Jung-Der Wang
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

3.  Nonparametric Benefit-Risk Assessment Using Marker Process in the Presence of a Terminal Event.

Authors:  Yifei Sun; Chiung-Yu Huang; Mei-Cheng Wang
Journal:  J Am Stat Assoc       Date:  2017-04-12       Impact factor: 5.033

4.  Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.

Authors:  David Ljungman; Kent Lundholm; Anders Hyltander
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

5.  Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls.

Authors:  Lukas Jyuhn-Hsiarn Lee; Chih-Wen Chung; Yu-Yin Chang; Yung-Chie Lee; Chih-Hsin Yang; Saou-Hsing Liou; Pang-Hsiang Liu; Jung-Der Wang
Journal:  Qual Life Res       Date:  2010-10-17       Impact factor: 4.147

6.  Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.

Authors:  Chiun Hsu; Jung-Der Wang; Jing-Shiang Hwang; Hwei-Fang Tien; Shueh-Mei Chang; Ann-Lii Cheng; Yao-Chang Chen; Jih-Luh Tang
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

7.  Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan.

Authors:  Tze-Wah Kao; Yu-Yin Chang; Pau-Chung Chen; Chih-Cheng Hsu; Yu-Kang Chang; Yu-Hung Chang; Lukas Jyuhn-Hsiarn Lee; Kwan-Dun Wu; Tun-Jun Tsai; Jung-Der Wang
Journal:  Perit Dial Int       Date:  2013-05-01       Impact factor: 1.756

8.  Quality-adjusted life-years and helmet use among motorcyclists sustaining head injuries.

Authors:  Hsin-Yi Lee; Yeh-Hsin Chen; Wen-Ta Chiu; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

9.  Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan.

Authors:  Mei-Chuan Hung; Hsin-Ming Lu; Likwang Chen; Ming-Shian Lin; Cheng-Ren Chen; Chong-Jen Yu; Jung-Der Wang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

10.  Optimal Intervals of Ultrasonography Screening for Early Diagnosis of Hepatocellular Carcinoma in Taiwan.

Authors:  Shih-Chiang Kuo; Chia-Ni Lin; Yih-Jyh Lin; Wei-Ying Chen; Jing-Shiang Hwang; Jung-Der Wang
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.